Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

575
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

496
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
496
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

552
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
552
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

459
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
459
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

611
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
611
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

358
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
358

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duplex ultrasound assessment after venous vascular closure of 16-17 F OD femoral venotomy: AMBULATE EXPAND ultrasound substudy.

Heart rhythm O2·2026
Same author

Outcomes of left atrial appendage closure vs oral anticoagulation after catheter ablation among patients with higher and lower stroke risk: A subanalysis of the OPTION clinical trial.

Heart rhythm·2026
Same author

Effect of Leadless Pacemaker Implantation on Tricuspid Regurgitation.

Journal of cardiovascular electrophysiology·2026
Same author

First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective Study.

JACC. Cardiovascular interventions·2026
Same author

Comparison of Two Pulsed Field Ablation Systems for Atrial Fibrillation: One-Year Outcomes From a Multicenter Registry.

Journal of cardiovascular electrophysiology·2026
Same author

Increased risk of lead transection and procedural complexity during extraction of thin-diameter, single filar pacemaker leads.

Heart rhythm·2026
Same journal

Sweating the Details: A Reflective Pause in our Procedural Workflow.

Cardiac electrophysiology clinics·2026
Same journal

Patent Foramen Ovale and Atrial Septal Defect.

Cardiac electrophysiology clinics·2026
Same journal

Patent Foramen Ovale Embryology, Anatomy, and Physiology.

Cardiac electrophysiology clinics·2026
Same journal

Management of Arrhythmias in the Cardiovascular Intensive Care Unit.

Cardiac electrophysiology clinics·2026
Same journal

Left Ventricular Assist Device Emergencies: Diagnosis and Management.

Cardiac electrophysiology clinics·2026
Same journal

Advanced Critical Care Techniques in the Field.

Cardiac electrophysiology clinics·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

Pacing-Induced Cardiomyopathy.

Faisal M Merchant1, Suneet Mittal2

  • 1Cardiology Division, Emory University School of Medicine, 550 Peachree Street North East, Atlanta, GA 3030, USA.

Cardiac Electrophysiology Clinics
|September 3, 2018
PubMed
Summary
This summary is machine-generated.

Pacing-induced cardiomyopathy (PICM) affects some patients with high right ventricular pacing burden. His bundle pacing may prevent this condition before it develops, offering a new therapeutic strategy.

Keywords:
High-burden right ventricular pacingPacemakerPacing-induced cardiomyopathy

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

3.1K

Related Experiment Videos

Last Updated: Feb 5, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

3.1K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiomyopathy Research

Background:

  • Pacing-induced cardiomyopathy (PICM) is a known risk in patients requiring significant right ventricular (RV) pacing.
  • Current methods for identifying patients at high risk for PICM are insufficient.
  • Existing treatment for PICM involves upgrading to cardiac resynchronization therapy after cardiomyopathy develops.

Purpose of the Study:

  • To explore the potential of His bundle pacing as a preventative measure for pacing-induced cardiomyopathy.
  • To address the limitations in identifying patients susceptible to RV pacing-induced heart muscle dysfunction.

Main Methods:

  • Review of existing literature on pacing-induced cardiomyopathy.
  • Analysis of the physiological effects of His bundle pacing versus traditional RV pacing.
  • Evaluation of the potential for His bundle pacing to mitigate RV pacing-related cardiac remodeling.

Main Results:

  • High-burden RV pacing can lead to cardiomyopathy in a subset of patients.
  • Many patients tolerate RV pacing without apparent harm, highlighting diagnostic challenges.
  • Cardiac resynchronization therapy is a treatment option once PICM is established.

Conclusions:

  • His bundle pacing presents a promising approach to potentially prevent PICM.
  • This pacing strategy may offer an alternative to traditional RV pacing, reducing the risk of cardiomyopathy.
  • Further research is warranted to confirm the prophylactic benefits of His bundle pacing in preventing PICM.